The responsiveness of joint counts, patient-reported measures and proposed composite scores in hand osteoarthritis: Analyses from a placebo-controlled trial

Annals of the Rheumatic Diseases

Volumn 69, Issue 8, 2010, Pages 1436-1440

  Haugen, I K ^a   Slatkowsky Christensen, B ^a   Lessem, J ^b   Kvien, T K ^a,c  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b Department of Preclinical Development and Formulations   (United States)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; PLACEBO; PREDNISOLONE;

ARTICLE; CARPOMETACARPAL JOINT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; FEMALE; HAND DISEASE; HUMAN; INTERPHALANGEAL JOINT; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; METACARPOPHALANGEAL JOINT; OSTEOARTHRITIS; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOFT TISSUE; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIRHEUMATIC AGENTS; DIPYRIDAMOLE; DRUG COMBINATIONS; FEMALE; HAND JOINTS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN MEASUREMENT; PREDNISOLONE; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77955443644     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.100156     Document Type: Article

References (33)

1. Dahaghin S, Bierma-Zeinstra SM, Ginai AZ, et al. Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study). Ann Rheum Dis 2005;64:682-7.
2. Slatkowsky-Christensen B, Mowinckel P, Loge JH, et al. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data. Arthritis Rheum 2007;57:1404-9.
3. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull WHO 2003;81:646-56.
4. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729-40.
5. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
6. Balsa A, Carmona L, González-Alvaro I, et al. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol 2004;31:40-6.
7. Smolen JS, Breedveld FC, Schiff MH, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003;42:244-57.
8. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23(5 Suppl 39):S100-8.
9. Wolfe F, Michaud K, Pincus T. A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II). J Rheumatol 2005;32:2410-15.
10. van Gestel AM, Prevoo ML, van't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996;39:34-40.
11. Bellamy N, Kirwan J, Boers M, et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 1997;24:799-802.
12. Altman R, Brandt K, Hochberg M, et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthr Cartil 1996;4:217-43.
13. Dougados M, Leclaire P, van der Heijde D, et al. Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthr Cartil 2000;8:395-403.
14. Pham T, Van Der Heijde D, Lassere M, et al. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol 2003;30:1648-54.
15. Maheu E, Altman RD, Bloch DA, et al. Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International. Osteoarthr Cartil 2006;14:303-22.
16. Kloppenburg M, Stamm T, Watt I, et al. Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper. Ann Rheum Dis 2007;66:1157-61.
17. Slatkowsky-Christensen B, Haugen IK, Kvien TK. Distribution of joint involvement in women with hand osteoarthritis and associations between joint counts and patient-reported outcome measures. Ann Rheum Dis 2010;54:198-201.
18. Kvien TK, Fjeld E, Slatkowsky-Christensen B, et al. Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis. Ann Rheum Dis 2008;67:942-8.
19. Altman R, Alarcón G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990;33:1601-10.
20. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
21. Bellamy N, Campbell J, Haraoui B, et al. Dimensionality and clinical importance of pain and disability in hand osteoarthritis: development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index. Osteoarthr Cartil 2002;10:855-62.
22. Bellamy N, Campbell J, Haraoui B, et al. Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness. Osteoarthr Cartil 2002;10:863-9.
23. Massy-Westropp N, Krishnan J, Ahern M. Comparing the AUSCAN Osteoarthritis Hand Index, Michigan Hand Outcomes Questionnaire, and Sequential Occupational Dexterity Assessment for patients with rheumatoid arthritis. J Rheumatol 2004;31:1996-2001.
24. Wells G, Li T, Maxwell L, et al. Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 2008;67:260-5.
25. Liang MH, Larson MG, Cullen KE, et al. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985;28:542-7.
26. Allen KD, Jordan JM, Renner JB, et al. Validity, factor structure, and clinical relevance of the AUSCAN Osteoarthritis Hand Index. Arthritis Rheum 2006;54:551-6.
27. Slatkowsky-Christensen B, Kvien TK, Bellamy N. Performance of the Norwegian version of AUSCAN - a disease-specific measure of hand osteoarthritis. Osteoarthr Cartil 2005;13:561-7.
28. Leeb BF, Sautner J, Andel I, et al. SACRAH: a score for assessment and quantification of chronic rheumatic affections of the hands. Rheumatology (Oxford) 2003;42:1173-8.
29. Dreiser RL, Maheu E, Guillou GB, et al. Validation of an algofunctional index for osteoarthritis of the hand. Rev Rheum Engl Ed 1995;62(6 Suppl 1):43S-53.
30. Dreiser RL, Maheu E, Guillou GB. Sensitivity to change of the functional index for hand osteoarthritis. Osteoarthr Cartil 2000;8(Suppl A):S25-8.
31. Duruöz MT, Poiraudeau S, Fermanian J, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 1996;23:1167-72.
32. Poiraudeau S, Chevalier X, Conrozier T, et al. Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis. Osteoarthr Cartil 2001;9:570-7.
33. Boers M, Brooks P, Strand CV, et al. The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol 1998;25:198-9.